JG
AXNX

Joel Greenblatt’s Axonics, Inc. Common Stock AXNX Stock Holding History

Joel Greenblatt’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,387
Closed -$358K – 1456
2023
Q3 		$358K Buy
6,387
+175
+3% +$9.85K 0.01% 1062
2023
Q2 		$314K Sell
6,212
-17,894
-74% -$952K 0.01% 1105
2023
Q1 		$1.32M Buy
24,106
+1,941
+9% +$113K 0.03% 658
2022
Q4 		$1.39M Sell
22,165
-11,928
-35% -$792K 0.04% 568
2022
Q3 		$2.4M Buy
+34,093
New +$2.35M 0.07% 331

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Joel Greenblatt's AXNX Position: Q4 2023 in Review

Joel Greenblatt sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 6,387 shares — an estimated $358K sold.

Joel Greenblatt first reported a position in AXNX in Q3 2022 and held it in 5 quarters. The position peaked at $2.4M in Q3 2022. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

  • Joel Greenblatt reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Joel Greenblatt sold 6,387 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $358K.
  • Joel Greenblatt first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Joel Greenblatt's Axonics, Inc. Common Stock position peaked at $2.4M in Q3 2022.
  • 230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.